Apr. 18 at 12:31 PM
$KLRA: Clinical‑stage biopharma, speculative “unwritten story,” but liquidity is a risk.
$AVEX: Cancer drug developer with upcoming data readouts — early pattern looks like HOOD.
$NBIS: AI infrastructure play, strong narrative but fierce competition — watch for margin bottom.
$HIMS: Telehealth + consumer brand, stable subs, but valuation is no longer cheap — more mid‑term hold.
$ONDS: Radar/communication + defense/drone, highly volatile, event‑driven.